Hamps Bio Limited has issued a regulatory disclosure regarding an upcoming board meeting scheduled for Friday, November 6, 2026. The meeting will be held at the registered office of the company.
The primary agenda items for the board meeting include:
- Consideration and approval of the Unaudited Standalone Financial Results of the Company for the half year ended September 30, 2026
- Consideration and approval of the Unaudited Consolidated Financial Results of the Company for the half year ended September 30, 2026
- Review and approval of the Limited Review Report accompanying the financial results
- Any other business that may be taken up with permission of the Chair
The disclosure is made in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication is addressed to BSE Limited and requests the exchange to take the information on record.
The document is digitally signed by Ravi Baheti, Company Secretary (Membership No.: A49472) on behalf of Hamps Bio Limited on November 3, 2026, at 17:11:06 IST.